{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:34:20Z","timestamp":1776918860594,"version":"3.51.2"},"reference-count":128,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"the European Regional Development Fund"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/13543776.2021.1917549","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T09:44:01Z","timestamp":1619430241000},"page":"809-836","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["A patent review of glutaminyl cyclase inhibitors (2004\u2013present)"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-3834","authenticated-orcid":false,"given":"Judite R.M.","family":"Coimbra","sequence":"first","affiliation":[{"name":"Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal"},{"name":"Center for Neuroscience and Cell Biology (CNC), Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0779-6083","authenticated-orcid":false,"given":"Jorge A.R.","family":"Salvador","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal"},{"name":"Center for Neuroscience and Cell Biology (CNC), Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal"}]}],"member":"301","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.11.3628"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.22.10059"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.07337.x"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.03.078"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.229385"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2015-0192"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201100158"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309077200"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504184102"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20071073"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170712"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.1995.tb00780.x"},{"key":"cit0013","first-page":"606","volume":"13","author":"Goren HJ","year":"1977","journal-title":"Mol Pharmacol"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.2.631"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1872"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1790"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9541-3"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0053"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040324"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis729"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1021\/bi800250p"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1021\/bi900818a"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0356-z"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-019-0177-0"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100263"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1088784"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20110535"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2019-0163"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1007\/s00775-018-1605-1"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.3390\/md14110203"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.08.029"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2016.03.064"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1021\/jm050756e"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2015.08.002"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90301-1"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3490"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2006.08.003"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05471.x"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.185819"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1794-11.2011"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040924"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-14-108"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044674"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.05.005"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-131535"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.06.021"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0266-6"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0505-x"},{"key":"cit0049","first-page":"1","volume":"00","author":"Gunn AP","year":"2020","journal-title":"J Neurochem"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.08.045"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1395-2"},{"key":"cit0052","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/iep.12020","volume":"94","author":"Cynis H","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-020-02013-x"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121623109"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120142"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1604268113"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.05.026"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226661"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-4-27"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21423"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184541"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9110944"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau3333"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2018.10.022"},{"key":"cit0065","unstructured":"Probiodrug AG, assignee. Use of effectors of glutaminyl and glutamate cyclases. Patent WO2004098625A2. 2004"},{"key":"cit0066","unstructured":"Probiodrug AG, assignee. Inhibitors of Glutaminyl Cyclase. Patent WO2004098591A2. 2004."},{"key":"cit0067","unstructured":"Probiodrug AG, assignee. Novel inhibitors of glutaminyl cyclase. Patent WO2005075436A2. 2005"},{"key":"cit0068","unstructured":"Probiodrug AG, assignee. Use of effectors of glutaminyl and glutamate cyclases. Patent WO2005039548A2. 2005"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1021\/jm900969p"},{"key":"cit0070","unstructured":"Probiodrug AG, assignee. Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors. Patent WO2008128981A1. 2008"},{"key":"cit0071","unstructured":"Probiodrug AG, assignee. Novel inhibitors. Patent WO2008128987A1. 2008"},{"key":"cit0072","unstructured":"Probiodrug AG, assignee. Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors. Patent WO2008128982A1. 2008"},{"key":"cit0073","unstructured":"Probiodrug AG, assignee. Cyano-guanidine derivatives as glutaminyl cyclase inhibitors. Patent WO2008128983A1. 2008"},{"key":"cit0074","unstructured":"Probiodrug AG, assignee. Thiourea derivatives as glutaminyl cyclase inhibitors. Patent WO2008128985A1. 2008"},{"key":"cit0075","unstructured":"Probiodrug AG, assignee. Urea derivatives as glutaminyl cyclase inhibitors. Patent WO2008128986A1. 2008"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1021\/jm4001709"},{"key":"cit0077","unstructured":"Probiodrug AG, assignee. Novel inhibitors of glutaminyl cyclase. Patent WO2008065141A1. 2008"},{"key":"cit0078","unstructured":"Probiodrug AG, assignee. Novel inhibitors. Patent WO2011107530A2. 2011"},{"key":"cit0079","unstructured":"Probiodrug AG, assignee. 3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases. Patent WO2008055945A1. 2008."},{"key":"cit0080","unstructured":"Probiodrug AG, assignee. Novel inhibitors of glutaminyl cyclase. Patent WO2008055947A1. 2008"},{"key":"cit0081","unstructured":"Probiodrug AG, assignee. Novel inhibitors of glutaminyl cyclase. Patent WO2008055950A1. 2008."},{"key":"cit0082","unstructured":"Probiodrug AG, assignee. Aminopyrimidine derivatives as glutaminyl cyclase inhibitors. Patent WO2008128984A1. 2008"},{"key":"cit0083","unstructured":"Probiodrug AG, assignee. Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase. Patent WO2008110523A1. 2008"},{"key":"cit0084","unstructured":"Probiodrug AG, assignee. Novel inhibitors. Patent WO2010026212A1. 2010"},{"key":"cit0085","unstructured":"Probiodrug AG, assignee. Use of isoQC inhibitors. Patent WO2010026209A1. 2010."},{"key":"cit0086","unstructured":"Probiodrug AG, assignee. Heterocylcic derivatives as inhibitors of glutaminyl cyclase. Patent WO2011029920A1. 2011"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.240614"},{"key":"cit0088","unstructured":"Probiodrug AG, assignee. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). Patent WO2011110613A1. 2011"},{"key":"cit0089","unstructured":"Probiodrug AG, assignee. Benzimidazole derivatives as inhibitors of Glutaminyl Cyclase. Patent WO2012123563A1. 2012."},{"key":"cit0090","unstructured":"Probiodrug AG, assignee. Novel Inhibitors Patent WO2011131748A2. 2011."},{"key":"cit0091","unstructured":"Probiodrug AG, assignee. Radiolabelled glutaminyl cyclase inhibitors. Patent WO2012163773A1. 2012"},{"key":"cit0092","unstructured":"Probiodrug AG, assignee. Novel inhibitors. Patent WO2014140279A1. 2014."},{"key":"cit0093","unstructured":"Probiodrug AG, assignee. Novel inhibitors. Patent WO2018178384A1. 2018."},{"key":"cit0094","unstructured":"Probiodrug AG, assignee. Inhibitors of glutaminyl cyclase. Patent WO2019063414A1. 2019"},{"key":"cit0095","unstructured":"Leibniz-Institut f\u00fcr Pflanzenbiochemie; Hochschule Anhalt, assignee. Sulfolipids as new Glutaminyl Cyclase inhibitors. Patent WO 2017046256A1. 2017."},{"key":"cit0096","unstructured":"Shenzhen University, assignee. Glutaminyl cyclase inhibitor. Patent CN105384692A. 2016."},{"key":"cit0097","unstructured":"Shenzhen University, assignee. Preparation method and application of glutaminyl cyclase (QC) inhibitor. Patent CN105384691A. 2016."},{"key":"cit0098","unstructured":"Shenzhen University, assignee. Glutaminyl cyclase inhibitor containing 4-imidazolyl group. Patent CN108912051A. 2018."},{"key":"cit0099","unstructured":"Shenzhen University, assignee. Preparation method and application of 4-imidazolyl-containing glutaminyl cyclase inhibitor. Patent CN109305942A. 2019."},{"key":"cit0100","unstructured":"Shenzhen University, assignee. Multi-target inhibitor acting on QC and GSK-3[beta]. Patent CN110903292A. 2020."},{"key":"cit0101","unstructured":"Shenzhen University, assignee. Preparation method and application of multi-target inhibitor acting on QC and GSK-3beta. Patent CN110950869A. 2020."},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00648"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105770"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.04.005"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00098"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2018.01.015"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2018.04.040"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00751"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1039\/C9RA05763C"},{"key":"cit0110","unstructured":"Medifron DBT Co., Ltd., assignee. Phenylthiourea derivatives preparation method thereof and pharmaceutical composition for use in preventing or treating glutaminyl cyclase activity related diseases containing the same as an active ingredient. Patent KR101909089B1. 2018."},{"key":"cit0111","unstructured":"National Health Research Institutes; Academia sinica assignee. benzimidazole compounds and use thereof for treating Alzheimer\u2019s disease or Huntington\u2019s disease. Patent US10584120B1. 2020."},{"key":"cit0112","unstructured":"Pharmenterprises, assignee. New inhibitor of Glutaminyl Cyclase and its use for treatment of lung and respiratory diseases. Patent RU2662559C1. 2017."},{"key":"cit0113","unstructured":"Pharmenterprises, assignee. New inhibitor of Glutaminyl Cyclase and its use. Patent RU2665633C1. 2017."},{"key":"cit0114","unstructured":"Pharmenterprises, assignee. Novel Glutaminyl Cyclase inhibitors and the use thereof in treatment of various diseases. Patent WO 2018217139A1. 2018."},{"key":"cit0115","unstructured":"Pharmenterprises, assignee. Use of a glutarimide derivative to treat diseases related to the aberrant activity of cytokines. Patent WO2019050429A1. 2019."},{"key":"cit0116","unstructured":"Therapeutics, assignee. Novel zinc complex, production and use of same. Patent WO2020040670A1. 2020."},{"key":"cit0117","unstructured":"Fraunhofer-Gesellschaft, assignee. Bacterial Glutaminyl Cyclases and inhibitors thereof for use in the treatment of periodontitis. Patent WO2018100159A1. 2018."},{"key":"cit0118","unstructured":"Fraunhofer-Gesellschaft, assignee. Novel inhibitors of bacterial Glutaminyl Cyclases for use in the treatment of periodontal and related diseases. Patent WO2019162458A1. 2019."},{"key":"cit0119","unstructured":"Academisch Ziekenhuis Leiden; Stichting het nederlands kanker inst antoni van lleuwenhoek ziekenhuis, assignee. treating pathological conditions by direct and indirect targeting of SIRP\u03b1-CD47 interaction. Patent WO2019022600A1. 2019."},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0431-6"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2019.09.014"},{"key":"cit0122","unstructured":"Vivoryon Therapeutics Announces Update on Phase 2b Alzheimer\u2019s Clinical Trial, VIVIAD [Internet]. 2020 [cited 18 Mar]. Available from: https:\/\/www.vivoryon.com\/vivoryon-therapeutics-announces-update-on-phase-2b-alzheimers-clinical-trial-viviad"},{"key":"cit0123","unstructured":"Vivoryon therapeutics announces enrollment of first patient in VIVIAD, European phase 2b Alzheimer\u2019s disease study with varoglutamstat (PQ912) [Internet]. 2020 [cited 15 Jul]. Available from: https:\/\/www.vivoryon.com\/vivoryon-therapeutics-announces-enrollment-of-first-patient-in-viviad-european-phase-2b-alzheimers-disease-study-with-varoglutamstat-pq912"},{"key":"cit0124","unstructured":"Vivoryon therapeutics provides update on US and EU Alzheimer\u2019s clinical trial program with PQ912 [Internet]. 2020 [cited 26 Jun]. Available from: https:\/\/www.vivoryon.com\/vivoryon-therapeutics-provides-update-on-us-and-eu-alzheimers-clinical-trial-program-with-pq912"},{"key":"cit0125","unstructured":"Vivoryon receives IND approval for varoglutamstat\u2018s (PQ912) phase 2 study in Alzheimer\u2019s disease [Internet]. 2020 [cited 04 Aug]. Available from: https:\/\/www.vivoryon.com\/vivoryon-receives-ind-approval-for-varoglutamstats-pq912-phase-2-study-in-alzheimers-disease"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.12.118"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100708"},{"key":"cit0128","doi-asserted-by":"crossref","first-page":"12112","DOI":"10.1002\/trc2.12112","volume":"7","author":"Lowe SL","year":"2021","journal-title":"Alzheimers Dement (N Y)"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2021.1917549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:44:24Z","timestamp":1724931864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2021.1917549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":128,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/13543776.2021.1917549"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2021.1917549","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}